Analyst Ralph Giacobbe works at CITI and is covering the the Healthcare sector with 533 price targets and ratings documented since 2008 spanning on 26 stocks. Previously, Ralph Giacobbe worked at CREDIT SUISSE.
Ralph Giacobbe's average stock forecast success ratio is 76.01% with an average time for price targets to be met of 235.73 days.
Most recent stock forecast was given on LH, Laboratory Corporation of America Holdings at 12-Dec-2022.
Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP - CLASS A).
The best stock recommendation documented was for APR at 5/17/2021. The price target of $33 was fulfilled within 4 days with a profit of $3.69 (12.59%) receiving and performance score of 31.47.
Average potential price target upside
Currently, out of the existing stock ratings of Ralph Giacobbe - 2 which are a Buy (18.18%), 2 which are a Sell (18.18%), 7 which are a Hold (63.64%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
83
$14.13 (20.52%)
88
4 days ago
4/7 (57.14%)
$7.75 (14.34%)
84
Hold
75
$6.13 (8.90%)
82
3 months ago
18/18 (100%)
$3.37 (8.25%)
245
Hold
80
$11.13 (16.16%)
87
3 months ago
15/18 (83.33%)
$2.72 (4.94%)
455
Buy
95
$26.13 (37.94%)
42
5 months 25 days ago
6/8 (75%)
$4.24 (11.27%)
518
Buy
103
$34.13 (49.56%)
95
9 months 11 days ago
10/13 (76.92%)
$13.15 (23.27%)
356
